Deviation in Dosing as per Randomisation schedule [GxP / QC / QA]

posted by Mrugank – India, 2012-08-18 20:22 (5064 d 05:06 ago) – Posting: # 9079
Views: 6,407

Dear All,

In double blind, three treatment study design - what are the resolution steps if Dosing treatment of two subjects have been interchange during Period - 1 ? Should we consider those two subjects continue for remaining study - if still Period 2 and Period 3 are remain ?

Is there any effect of it on result of study data?

Regards,
Mrugank


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
330 visitors (0 registered, 330 guests [including 43 identified bots]).
Forum time: 01:28 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5